Hepatitis B vaccine - Provalis
Latest Information Update: 27 May 1998
At a glance
- Originator Provalis
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 27 May 1998 Discontinued-Preclinical for Hepatitis B in United Kingdom (PO)
- 17 Apr 1996 New profile
- 17 Apr 1996 Preclinical development for Hepatitis B in United Kingdom (PO)